Study of MGTA-117 in Patients With Adult Acute Myeloid Leukemia (AML) and Myelodysplasia-Excess Blasts (MDS-EB)

Study Number
2258921
Phase
I/II
Age Group
Adult
Principal Investigator
Philip McCarthy
Purpose

This research study is designed to selectively deplete CD117-positive cells from participants with AML and MDS-EB.

Check your eligibility for this trial
Check now
Full Title

A PHASE I/II, DOSE-ESCALATION STUDY OF MGTA-117 IN PATIENTS WITH ADULT ACUTE MYELOID LEUKEMIA (AML) AND MYELODYSPLASIA-EXCESS BLASTS (MDS-EB)

ClinicalTrials.Gov ID
NCT05223699

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.